Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The appropriate strategy depends on age, medical history, symptoms, family history, medications, previous results, and whether a finding would change clinical decision-making
doi: 10.1530/REP-15-0044 149 MaXHayesEPrizantHSrivastavaRKHammesSRSenAet al
A SUSTAIN 6 clinical trial was conducted to assess the safety and efficacy of semaglutide for managing cardiovascular diseases and type diabetes mellitus
The primary endpoint was all-cause mortality, and secondary endpoints were AMI, ischemic stroke, hemorrhagic stroke, atrial fibrillation (A-Fib)/flutter, cardiac arrest, readmission rate, and achievement of HbA1c (blood sugar) levels below 7%
US$ 25.63
US$ 20.70
US$ 28.03
US$ 21.26
US$ 22.55
US$ 20.08
